Cynata Therapeutics Statistics

Total Valuation

ASX:CYP has a market cap or net worth of AUD 80.73 million. The enterprise value is 78.15 million.

Market Cap	80.73M
Enterprise Value	78.15M

Important Dates

The last earnings date was Friday, February 20, 2026.

Earnings Date	Feb 20, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:CYP has 237.45 million shares outstanding. The number of shares has increased by 26.09% in one year.

Current Share Class	237.45M
Shares Outstanding	237.45M
Shares Change (YoY)	+26.09%
Shares Change (QoQ)	+3.54%
Owned by Insiders (%)	8.50%
Owned by Institutions (%)	13.67%
Float	182.80M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	47.85
PB Ratio	23.83
P/TBV Ratio	23.83
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-9.30
EV / Sales	46.31
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-9.61

Financial Position

The company has a current ratio of 2.49

Current Ratio	2.49
Quick Ratio	2.36
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -112.99% and return on invested capital (ROIC) is -72.47%.

Return on Equity (ROE)	-112.99%
Return on Assets (ROA)	-62.05%
Return on Invested Capital (ROIC)	-72.47%
Return on Capital Employed (ROCE)	-254.54%
Weighted Average Cost of Capital (WACC)	9.95%
Revenue Per Employee	843,645
Profits Per Employee	-4.20M
Employee Count	2
Asset Turnover	0.19
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +44.68% in the last 52 weeks. The beta is 1.04, so ASX:CYP's price volatility has been similar to the market average.

Beta (5Y)	1.04
52-Week Price Change	+44.68%
50-Day Moving Average	0.35
200-Day Moving Average	0.25
Relative Strength Index (RSI)	45.68
Average Volume (20 Days)	199,645

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:CYP had revenue of AUD 1.69 million and -8.40 million in losses. Loss per share was -0.04.

Revenue	1.69M
Gross Profit	1.69M
Operating Income	-8.62M
Pretax Income	-8.40M
Net Income	-8.40M
EBITDA	-8.35M
EBIT	-8.62M
Loss Per Share	-0.04

Full Income Statement

Balance Sheet

The company has 2.59 million in cash and n/a in debt, giving a net cash position of 2.59 million or 0.01 per share.

Cash & Cash Equivalents	2.59M
Total Debt	n/a
Net Cash	2.59M
Net Cash Per Share	0.01
Equity (Book Value)	3.39M
Book Value Per Share	0.01
Working Capital	1.67M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -8.18 million and capital expenditures 50,000, giving a free cash flow of -8.13 million.

Operating Cash Flow	-8.18M
Capital Expenditures	50,000
Free Cash Flow	-8.13M
FCF Per Share	-0.03

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-511.09%
Pretax Margin	-498.03%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ASX:CYP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-26.09%
Shareholder Yield	-26.09%
Earnings Yield	-10.41%
FCF Yield	-10.07%

Stock Splits

The last stock split was on October 31, 2013. It was a reverse split with a ratio of 0.05.

Last Split Date	Oct 31, 2013
Split Type	Reverse
Split Ratio	0.05

Scores

ASX:CYP has an Altman Z-Score of -8.39 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-8.39
Piotroski F-Score	1